Helps reduce appetite
Helps you manage portions and eat less more naturally.
Start with 2.5 mg once weekly, with home-use guidance and follow-up tailored to each client.
Tirzepatide acts on GIP and GLP-1 receptors to support appetite and food-intake control.
Helps you manage portions and eat less more naturally.
Slows gastric emptying and helps you stay full longer between meals.
May improve insulin response in suitable clients after professional assessment.
Use once weekly, with one single-use pen per injection.
Actual results depend on individual response, diet, activity and consistency.
*Image shown for illustrative purposes. Results vary by individual.
Helps reduce hunger and support more controlled eating.
No daily injections; choose one consistent day each week.
Receive injection and storage guidance before taking it home.
Contact us through WhatsApp or Telegram whenever you need support.
Each box contains 2 pens. Use 1 pen weekly; every pen is single-use.
Starter stage • once weekly
Move to the next dose only after response and tolerance are assessed
Mounjaro is a prescription medicine. Do not start, increase, stop or add injections without assessment and guidance from a qualified professional.
Photos of Japanese-market boxes and pens help clients identify the 2.5 mg and 5 mg doses.
Packaging may vary by import market. Check the medicine name, strength, batch number, expiry date and storage condition when receiving the product.
Inject once on a consistent day
Use one single-use pen per injection
Use only after receiving guidance
Refrigerate; do not freeze; protect from light
Enter your measurements for an instant result. BMI is a screening measure and does not replace medical assessment.
| Height | Average | Slim | Thin |
|---|---|---|---|
| 150 cm | 49.5 kg | 45.0 kg | 42.8 kg |
| 152 cm | 50.8 kg | 46.6 kg | 42.8 kg |
| 154 cm | 52.2 kg | 47.4 kg | 45.1 kg |
| 156 cm | 53.5 kg | 48.7 kg | 46.2 kg |
| 158 cm | 54.9 kg | 49.9 kg | 47.4 kg |
| 160 cm | 56.3 kg | 51.2 kg | 48.6 kg |
| 162 cm | 57.7 kg | 52.5 kg | 49.9 kg |
| 164 cm | 59.2 kg | 53.8 kg | 51.1 kg |
| 166 cm | 60.6 kg | 55.1 kg | 52.4 kg |
| 169 cm | 62.1 kg | 56.1 kg | 53.6 kg |
| 170 cm | 63.6 kg | 57.8 kg | 54.9 kg |
Enter your height and weight, then selectCalculate BMI.
BMI is only a screening tool. Suitability also depends on medical conditions, current medicines, personal history and professional assessment.
Once weekly on a consistent day. Use one pen per injection, and each pen is single-use.
The pen is designed for convenient use, but clients should receive guidance on technique, injection sites, site rotation and disposal.
Some people notice reduced appetite during the first few weeks. The amount and timing of weight change vary by individual.
Keep refrigerated at 2–8°C, do not freeze, protect from direct light and keep in the original box until use.
No. Dose escalation should be based on response, side effects and professional assessment.